← FDA DRUG APPROVALS

FDA NDA · NDA022244

LUSEDRA

Sponsor: EISAI INC

APPLICATION
NDA022244
TYPE
NDA
ORIGINAL APPROVAL
2008-12-08
LATEST ACTION
2008-12-08
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

LUSEDRADiscontinued
FOSPROPOFOL DISODIUM 1050MG/30ML (35MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2008-12-08Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →